Designing Collagen for biomedical needs. ECM Technologies, LLC is located in Houston, Texas and utilizes bacterial-derived proteins as a platform for designing collagens for biomedical needs. The core technology was developed in the laboratory of Dr. Magnus Hook at the Texas A&M Health Science Center

The ECMT platform technology is the development of Designer Collagens that have targeted cell instruction through engineered bacterial collagens. ECMT will fast-track novel regenerative technology from the research bench to the market place. We will develop these "ideas" and carry them through proof of principal, prototype development, clinical data, and FDA approval milestones. Upon FDA approval, ECMT will seek partnerships for the manufacturing, sales and distribution of its products. Aligning with strategic partners for these steps, allows ECMT to focus on innovation.


July 19, 2015: ECMT listed as one of Houston Chronicles tech startups to keep an eye on

June 3, 2015: ECMT earns second place and $5,000 for its one-minute pitch of biomaterial dressing for chronic wounds

May 5, 2015: ECMT competes in Medical World Americas through TMC|X

April 21, 2015: ECMT featured in Texas A&M Health Science Center news

April 1, 2015: ECMT accepted into TMC|X accelerator program